Cochlear Annual Report 2006 : Board of directors


Mr Tommie CE Bergman Chairman Age 61. DipEng, Grad DipMarketing, FAICD, FAIM Appointed Chairman 22 October 2002. Appointed director and Deputy Chairman 1 January 2002. Director of Smorgon Steel Group Limited since 1999. Member of Advisory Board of Caliburn Partnership Pty Ltd. Former Chairman (2003 – 2005) and Deputy Chairman (2001 – 2002) of WMC Resources Limited and director of Amcor Limited (1997 – 2003) and Atlas Copco Australia Pty Ltd. Former Chairman and Managing Director of Asea Brown Boveri Australasia Pty Ltd (1991 – 2002). Prior to that held CEO and Chairman positions in the ABB Group in Singapore, India, Portugal and the United States. Chairman of the Nominations Committee. Member of the Audit Committee and Remuneration Committee.
Dr Chris G Roberts CEO/President Age 52. BE (Hons), MBA, PhD, FAICD, FTSE Appointed 1 February 2004 Chief Executive Officer of Cochlear Limited. Director of ResMed Inc since 1992 and Chairman of Research Australia. Dr Roberts has worked in the medical device industry for more than 30 years in a number of senior management positions. Member of the Medical Science Committee and Technology and Innovation Committee.
Mr Paul R Bell Age 60. BA, MA (Hons) Appointed 1 August 2005 Director of Bio-Link Partners Limited since 2005 and GroPep Limited since 2003. Extensive executive career spanning 30 years with the international pharmaceutical company, Merck & Co Inc (Managing Director – Australia, 1988 – 1997; President of the Asia Pacific Human Health Division, 1997– 2002). Member of the Global Merck Management Committee. Chairman of the Remuneration Committee. Member of the Nominations Committee and Technology and Innovation Committee.
Prof Edward Byrne, AO Age 54. DSc, MD, MBA, FRCP, FRACP Appointed 1 July 2002 Dean of Faculty of Medicine, Nursing and Health Sciences at Monash University, Melbourne, Deputy Chair of Neurosciences Victoria Limited. Director of Neurosciences Australia Limited. Board member of the Baker Medical Research Institute, Burnet Medical Research Institute, Prince Henry’s Medical Research Institute, Southern Health and Mental Health Research Institute. Chairman of the Medical Science Committee. Member of the Nominations Committee and Technology and Innovation Committee.
Mr Rick Holliday-Smith Age 56. BA (Hons), FAICD Appointed 1 March 2005 Chairman of SFE Corporation Limited since 1999 until de-listing in July 2006. Director of DCA Group Limited since 2004, MIA Group Limited (2000 – 2004) until acquired by DCA Group Limited, Servcorp Limited since 1999 and ASX Limited since July 2006. Chairman of Snowy Hydro Limited (not listed) since May 2006. Former director of Exco Resources NL (1999 – 2006). Former President of NationsBank-CRT, Chicago and Managing Director of Hong Kong Bank Limited, London. Chairman of the Audit Committee. Member of the Nominations Committee and Remuneration Committee.
Mr Peter J North, AM Age 72. BE, MBA, FAIM, FAICD, FTSE, FIE Aust Appointed 11 February 1997 Chairman of the Warren Centre for Advanced Engineering and director of the Australian Academy of Technological Sciences and Engineering. A director of listed companies for more than 20 years. FormerCEO in industry and management consulting. Chairman of the Technology and Innovation Committee. Member of the Audit Committee and Nominations Committee.
Mr Donal P O’Dwyer Age 53. BECivil, MBA Appointed 1 August 2005 President of Cordis Cardiology (Johnson & Johnson medical device business unit with annual turnover of over USD 2 billion) between 2000 and 2004. Chairman of Atcor Medical since 2004 and a director of Sunshine Heart Inc since 2004, Mesoblast Limited since 2004 and Angioblast Systems Inc since 2005. Member of the Medical Science Committee, Nominations Committee and Technology and Innovation Committee.
Mr Dr John L Parker Age 63. BLaws Appointed 19 March 2002 Chief Technology Officer of Cochlear Limited. Director of Premier Bionics Limited since 2004. Governor of the Warren Centre for Advanced Engineering, Board member of the Cooperative Research Centre for Cochlear Implants and Hearing Innovation. Has an academic appointment as a Visiting Fellow at the Department of Maths, Physics, Computing and Electronics at Macquarie University, NSW. Member of the Technology and Innovation Committee.
Mr Justus H Veeneklaas Age 64. BLaws Appointed 17 March 1998 Director of PowerTel Limited since 2004. Member of the Sydney Symphony Orchestra Council since 1990. Former Chairman of Request DSL Pty Limited (2000 – 2004). Former Chairman and Chief Executive of Philips Electronics Australia (1990 – 1998). Prior to that, held CEO positions in the Philips Group in Hong Kong and the United Kingdom. Member of the Nominations Committee, Remuneration Committee and Technology and Innovation Committee.